Kreitman; Robert J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kreitman; Robert J..The latest application filed is for "mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells".

Company Profile

0.5.7

Kreitman; Robert J. - Potomac MD
Kreitman, Robert J - Potomac MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Mutated Anti-cd22 Antibodies With Increased Affinity To Cd22-expressing Leukemia Cells App 20120258106 - Pastan; Ira H ; et al.	2012-10-11
Mutated Anti-cd22 Antibodies With Increased Affinity To Cd22-expressing Leukemia Cells App 20110065185 - Pastan; Ira H. ; et al.	2011-03-17
Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells Grant 7,777,019 - Pastan , et al. August 17, 2	2010-08-17
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the Fv to lower the isoelectric point Grant 7,521,054 - Pastan , et al. April 21, 2	2009-04-21
Mutated Anti-CD22 Antibodies With Increased Affinity To CD22-Expressing Leukemia Cells App 20090004734 - Pastan; Ira H. ; et al.	2009-01-01
Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells Grant 7,355,012 - Pastan , et al. April 8, 2	2008-04-08
Elisa assay of serum soluble cd22 to assess tumor burnden/relapse in subjects with leukemia and lymphoma App 20050244828 - Kreitman, Robert J. ; et al.	2005-11-03
Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells App 20050118182 - Pastan, Ira H ; et al.	2005-06-02
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point App 20040091489 - Pastan, Ira H. ; et al.	2004-05-13
Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates App 20040018203 - Pastan, Ira ; et al.	2004-01-29
Circularly permuted ligands and circularly permuted chimeric molecules Grant 6,011,002 - Pastan , et al. January 4, 2	2000-01-04
Fusion proteins comprising circularly permuted ligands Grant 5,635,599 - Pastan , et al. June 3, 1	1997-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.